HomeCompareGLVNF vs MRK

GLVNF vs MRK: Dividend Comparison 2026

GLVNF yields 2857.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLVNF wins by $285724556560.03M in total portfolio value
10 years
GLVNF
GLVNF
● Live price
2857.14%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$285724556560.08M
Annual income
$267,319,527,558,731,650.00
Full GLVNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLVNF vs MRK

📍 GLVNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLVNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLVNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLVNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLVNF
Annual income on $10K today (after 15% tax)
$242,857.14/yr
After 10yr DRIP, annual income (after tax)
$227,221,598,424,921,900.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GLVNF beats the other by $227,221,598,424,913,570.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLVNF + MRK for your $10,000?

GLVNF: 50%MRK: 50%
100% MRK50/50100% GLVNF
Portfolio after 10yr
$142862278280.07M
Annual income
$133,659,763,779,370,720.00/yr
Blended yield
93.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLVNF
No analyst data
Altman Z
-0.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLVNF buys
0
MRK buys
0
No recent congressional trades found for GLVNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLVNFMRK
Forward yield2857.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$285724556560.08M$56.8K
Annual income after 10y$267,319,527,558,731,650.00$9,798.13
Total dividends collected$284448663636.43M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLVNF vs MRK ($10,000, DRIP)

YearGLVNF PortfolioGLVNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$296,414$285,714.29$11,206$366.19+$285.2KGLVNF
2$8,232,097$7,914,934.20$12,650$502.35+$8.22MGLVNF
3$214,243,566$205,435,221.63$14,407$694.19+$214.23MGLVNF
4$5,225,999,702$4,996,759,086.15$16,585$967.82+$5225.98MGLVNF
5$119,502,966,841$113,911,147,159.88$19,342$1,363.89+$119502.95MGLVNF
6$2,562,267,139,226$2,434,398,964,706.24$22,913$1,947.19+$2562267.12MGLVNF
7$51,522,962,512,220$48,781,336,673,248.19$27,662$2,823.89+$51522962.48MGLVNF
8$971,869,901,477,056$916,740,331,588,980.50$34,159$4,173.35+$971869901.44MGLVNF
9$17,200,961,683,505,388$16,161,060,888,924,940.00$43,337$6,308.80+$17200961683.46MGLVNF
10$285,724,556,560,082,430$267,319,527,558,731,650.00$56,776$9,798.13+$285724556560.03MGLVNF

GLVNF vs MRK: Complete Analysis 2026

GLVNFStock

Gallant Venture Ltd., an investment holding company, operates as an independent utilities provider in Indonesia. The company operates through Industrial Parks; Utilities; Resort Operations; and Property Development segments. The Industrial Parks segment develops, constructs, operates, and maintains industrial properties in Batam and Bintan Islands with supporting infrastructure activities. The Utilities segment provides electricity, water supply, telecommunications, waste management, and sewage treatment services to the industrial parks and resorts in Batam and Bintan Islands. This segment operates 19 dual fuel fired generators with an installed capacity of approximately 130MW at Batamindo Industrial Park; 6 generators with an installed capacity of approximately 24MW at Bintan Industrial Estate; and 4 generators with an installed capacity of approximately 20MW at Bintan Resorts. The Resort Operations segment offers services to resort operators in Bintan Resort, including ferry services and ferry terminal operations, tour operations, property rental, workers accommodation, security, fire-fighting, medical support, and estate and township maintenance services, as well as facilities required by resort operators. The Property Development segment develops industrial and resort properties in Batam and Bintan Islands. It also offers business management consultancy services; and wholesales hotels, resorts, and golf courses. The company was incorporated in 2003 and is headquartered in Singapore.

Full GLVNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLVNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLVNF vs SCHDGLVNF vs JEPIGLVNF vs OGLVNF vs KOGLVNF vs MAINGLVNF vs JNJGLVNF vs ABBVGLVNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.